Rushil Patel, Yongzhao Huang, Aisha Mergaert, Emer Clarke. "primary CD34+ derived mast cells provide an excellent platform to assess single agent and combination therapies for mastocytosis." Blood, 2025. doi:10.1182/blood-2025-7278